MSB 0.93% $1.09 mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-219

  1. 12,340 Posts.
    lightbulb Created with Sketch. 3367
    No chance of that mate!

    If the results are overwhelming - don't worry, this will be shouted!

    I don't think the trial can continue as such, but those who have been enrolled may receive Rem-L instead of placebo. This will have to be announced as it is different to the original trial design
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
0.010(0.93%)
Mkt cap ! $1.221B
Open High Low Value Volume
$1.07 $1.10 $1.05 $3.427M 3.208M

Buyers (Bids)

No. Vol. Price($)
6 24244 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 56251 14
View Market Depth
Last trade - 14.25pm 17/06/2024 (20 minute delay) ?
Last
$1.09
  Change
0.010 ( 0.06 %)
Open High Low Volume
$1.07 $1.10 $1.05 736239
Last updated 14.44pm 17/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.